This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Heat-iMVA improved T cell and antibody responses, extending survival and delaying tumor growth.
Why it matters
Enhancing immune responses in vaccines is crucial for effective cancer and COVID-19 treatments. Heat-iMVA could lead to more effective vaccines.
How the study worked
The study employed a therapeutic vaccination model using tumor neoantigen peptide vaccines and SARS-CoV-2 spike protein to assess the adjuvant effects of heat-iMVA.
What this study cannot tell us
The study primarily focuses on preclinical models, and results may not directly translate to human applications.
Read the original research
Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.
NPJ vaccines, 7(1), 120
Citation
Yang, Ning; Garcia, Aitor; Meyer, Cindy; Tuschl, Thomas; Merghoub, Taha; Wolchok, Jedd D; Deng, Liang. (2022). Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.. NPJ vaccines, 7(1), 120. https://doi.org/10.1038/s41541-022-00542-5